BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11959206)

  • 1. Efficacy and safety of basiliximab in pediatric renal transplantation.
    García-Meseguer C; Roldán M; Melgosa M; Alonso A; Peña A; Espìnosa L; Navarro M
    Transplant Proc; 2002 Feb; 34(1):102-3. PubMed ID: 11959206
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation.
    Boggi U; Vistoli F; Coppelli A; Marchetti P; Rizzo G; Mosca F
    Transplant Proc; 2001; 33(7-8):3201-2. PubMed ID: 11750373
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.
    Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A
    Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.
    Kumar MS; Kode RK; Pankewycz OG; Laftavi MR; Kumar AM; Damask AM; Vora M; Tomeny MB; Ferry E; Samartino BC; Sierka D; Lingaraju RM; Fyfe B
    Transplant Proc; 2001; 33(7-8):3762-3. PubMed ID: 11750602
    [No Abstract]   [Full Text] [Related]  

  • 5. Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
    Folkmane I; Bicans J; Amerika D; Chapenko S; Murovska M; Rosentals R
    Transplant Proc; 2001; 33(7-8):3209-10. PubMed ID: 11750377
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction.
    Garcia CD; Schneider L; Barros VR; Guimarães PC; Garcia VD
    Transplant Proc; 2002 Nov; 34(7):2533-4. PubMed ID: 12431513
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
    Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB
    Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
    Citterio F; Scatà MC; Romagnoli J; Pozzetto U; Nanni G; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1685-6. PubMed ID: 12176535
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
    Conti DJ; Isenberg A; Shen GK; Hahn A; Singh TP
    Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
    [No Abstract]   [Full Text] [Related]  

  • 12. Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.
    Lawen J; Keough-Ryan T; Clase C; Kiberd B
    Transplant Proc; 2001; 33(7-8):3223-5. PubMed ID: 11750382
    [No Abstract]   [Full Text] [Related]  

  • 13. Recovery of graft function in pediatric kidney transplantation is not affected by delayed introduction of cyclosporine.
    Cransberg K; Bouts AH; Cornelissen EA; Lilien MR; Van Hoeck KJ; Hop WC; Nauta J
    Transplantation; 2008 Nov; 86(9):1199-205. PubMed ID: 19005400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.
    Rahamimov R; Yussim A; After T; Lustig S; Bar-Nathan N; Shaharabani E; Shapira Z; Shabthai E; Mor E
    Transplant Proc; 2003 Mar; 35(2):653-4. PubMed ID: 12644082
    [No Abstract]   [Full Text] [Related]  

  • 15. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.
    Kandus A; Arnol M; Omahen K; Oblak M; Vidan-Jeras B; Kmetec A; Bren AF
    Transplantation; 2010 Apr; 89(8):1022-7. PubMed ID: 20075788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody basiliximab with low cyclosporine dose as initial immunosuppression.
    Boletis JN; Theodoropoulou H; Hiras T; Stamatiadis D; Darema M; Psimenou E; Stathakis C; Kostakis A
    Transplant Proc; 2001; 33(7-8):3184-6. PubMed ID: 11750366
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract]   [Full Text] [Related]  

  • 18. Within-patient controlled assessment of the influence of basiliximab on cyclosporine in pediatric de novo renal transplant recipients.
    Kovarik JM; Korn A; Chodoff L
    Transplant Proc; 2001; 33(7-8):3172-3. PubMed ID: 11750361
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of renal transplantation with different immunosuppressive regimens.
    Folkmane I; Bicans J; Chapenko S; Murovska M; Rosentals R
    Transplant Proc; 2002 Mar; 34(2):558-9. PubMed ID: 12009623
    [No Abstract]   [Full Text] [Related]  

  • 20. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber AO
    Transplant Proc; 2001; 33(1-2):1701-3. PubMed ID: 11267477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.